Buchan, Graham B.J.
Ong, Christian B.
Hecht II, Christian J.
DeCook, Charles A.
Spencer-Gardner, Luke S.
Kamath, Atul F.
Article History
Received: 11 October 2023
Accepted: 15 February 2024
First Online: 24 February 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board (06/03/2022; IRB#: 22–528).
: A waiver of informed consent was obtained prior to the initiation of this investigation.
: • Authors G.B.J.B., C.B.O., C.J.H., and L.S.SG. declare that they have no relevant competing interests. Authors C.A.D. and A.F.K. have the below disclosures:•C.A.D. •Royalties: DePuySynthes, Mizuho-OSI. •Speakers bureau: DePuySynthes, Medtronic. •Stock or stock options: JointPoint, JointVue.•A.F.K. •Royalties: Innomed, ZimmerBiomet. •Speakers bureau: ZimmerBiomet, Johnson and Johnson, BodyCad. •Paid consultant: ZimmerBiomet, Johnson and Johnson, BodyCad, United Ortho, Orthopedic Development. •Stock or stock options: ZimmerBiomet, Johnson and Johnson, Procter and Gamble. •Research support: Signature Orthopedics.